Collectively, NAT10 exhibits multifaceted, non-ac4C-dependent roles in regulating genome stability, DNA damage response, and chemoresistance through substrate-specific acetylation, positioning it as a context-dependent therapeutic target in cancer. Here, NAT10 is linked to cancer.